Literature DB >> 9199457

An in vitro model for infection with Leishmania major that mimics the immune response in mice.

M B Soares1, J R David, R G Titus.   

Abstract

By using a primary in vitro response specific for Leishmania major, normal T cells from resistant CBA/CaH-T6J and susceptible BALB/c mice commit to a Th1 and a Th2 response, respectively. Since commitment occurred, we measured the production of gamma interferon (IFN-gamma), interleukin-1 (IL-1), IL-2, IL-4, IL-5, IL-10, and IL-12, prostaglandin E2 (PGE2), transforming growth factor beta (TGF-beta), and nitric oxide in the first 7 days of the response to identify factors that are critical for Th1 and Th2 development. While cells from resistant CBA mice produced more IFN-gamma, IL-10, and nitric oxide, cells from susceptible BALB/c mice produced more IL-1alpha, IL-5, PGE2, and TGF-beta. Although substantial amounts of IL-12 were detected, IL-12 did not associate with either Th1 or Th2 development. We did not anticipate that cells from resistant CBA mice would make more IL-10 in vitro. However, this also occurred in vivo since CBA mice produced substantial amounts of IL-10 following infection with L. major. Moreover, adding anti-IL-10 to primary in vitro responses enhanced production of IFN-gamma and nitric oxide by cells from CBA and BALB/c mice. Therefore, IL-10 cannot be regarded as a cytokine that associates with susceptibility to infection with L. major. Finally, the data presented here suggest that a collection of factors that can be produced by accessory cells influence Th commitment (e.g., IL-1, PGE2, and TGF-beta favor Th2 development).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9199457      PMCID: PMC175399          DOI: 10.1128/iai.65.7.2837-2845.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  63 in total

1.  Roles of IFN-gamma and IFN-alpha in IL-12-induced T helper cell-1 development.

Authors:  C A Wenner; M L Güler; S E Macatonia; A O'Garra; K M Murphy
Journal:  J Immunol       Date:  1996-02-15       Impact factor: 5.422

2.  Effect of PGE2 and of agents that raise cAMP levels on macrophage activation induced by IFN-gamma and TNF-alpha.

Authors:  J Mauël; A Ransijn; S B Corradin; Y Buchmüller-Rouiller
Journal:  J Leukoc Biol       Date:  1995-08       Impact factor: 4.962

3.  Ex vivo evidence for PGE2 and LTB4 involvement in cutaneous leishmaniasis: relation with infection status and cytokine production.

Authors:  S Milano; F Arcoleo; M Dieli; R D'Agostino; G De Nucci; P D'Agostino; E Cillari
Journal:  Parasitology       Date:  1996-01       Impact factor: 3.234

Review 4.  The role of the innate immune response in Th1 cell development following Leishmania major infection.

Authors:  T Scharton-Kersten; P Scott
Journal:  J Leukoc Biol       Date:  1995-04       Impact factor: 4.962

5.  Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice.

Authors:  F P Heinzel; R M Rerko; F Ahmed; E Pearlman
Journal:  J Immunol       Date:  1995-07-15       Impact factor: 5.422

6.  In susceptible mice, Leishmania major induce very rapid interleukin-4 production by CD4+ T cells which are NK1.1-.

Authors:  P Launois; T Ohteki; K Swihart; H R MacDonald; J A Louis
Journal:  Eur J Immunol       Date:  1995-12       Impact factor: 5.532

7.  IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis.

Authors:  T Scharton-Kersten; L C Afonso; M Wysocka; G Trinchieri; P Scott
Journal:  J Immunol       Date:  1995-05-15       Impact factor: 5.422

8.  Divergent T-cell cytokine patterns in inflammatory arthritis.

Authors:  A K Simon; E Seipelt; J Sieper
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

9.  Sand fly vector saliva selectively modulates macrophage functions that inhibit killing of Leishmania major and nitric oxide production.

Authors:  L R Hall; R G Titus
Journal:  J Immunol       Date:  1995-10-01       Impact factor: 5.422

10.  Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major.

Authors:  S Stenger; H Thüring; M Röllinghoff; C Bogdan
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

View more
  6 in total

1.  Malnutrition alters the innate immune response and increases early visceralization following Leishmania donovani infection.

Authors:  G M Anstead; B Chandrasekar; W Zhao; J Yang; L E Perez; P C Melby
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

Review 2.  Reconciling protective and pathogenic roles of the NLRP3 inflammasome in leishmaniasis.

Authors:  Valerie Harrington; Prajwal Gurung
Journal:  Immunol Rev       Date:  2020-06-20       Impact factor: 12.988

3.  Influence of parasite load on the ability of type 1 T cells to control Leishmania major infection.

Authors:  Brian Hondowicz; Phillip Scott
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

4.  Interleukin-6 deficiency influences cytokine expression in susceptible BALB mice infected with Leishmania major but does not alter the outcome of disease.

Authors:  R G Titus; G K DeKrey; R V Morris; M B Soares
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

5.  Characterization of an I-E-restricted, gp63-specific, CD4-T-cell clone from Leishmania major-resistant C3H mice that secretes type 2 cytokines and exacerbates infection with L. major.

Authors:  Cynthia M Theodos; Robin V Morris; Jeanette V Bishop; Jeremy D Jones; W Robert McMaster; Richard G Titus
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

6.  IFN-gamma expression is up-regulated by peripheral blood mononuclear cells (PBMC) from non-exposed dogs upon Leishmania chagasi promastigote stimulation in vitro.

Authors:  Cleusa Alves Theodore Rodrigues; Luís Fábio da Silva Batista; Roberto Santos Teixeira Filho; Claire da Silva Santos; Cristiane Garboggini Pinheiro; Taís Fontoura de Almeida; Luiz Antônio Rodrigues de Freitas; Patrícia Sampaio Tavares Veras
Journal:  Vet Immunol Immunopathol       Date:  2008-10-31       Impact factor: 2.046

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.